Corporate Governance

Mayne Pharma's Corporate Governance Policies

Appendix 4G and 2019 Corporate Governance Statement (PDF)
Audit & Risk Committee Charter (PDF)
Board Charter (PDF)
Communications Policy (PDF)
Continuous Disclosure Policy (PDF)
Nomination Committee Charter (PDF)
Remuneration and People Committee Charter (PDF)
Science, Technology and Medical Committee Charter (PDF)
Risk Management Framework (PDF)
Securities Trading Policy (PDF)
Business Code of Conduct (PDF)
Misconduct & Whistleblowing Policy (PDF)
Anti-Bribery & Anti-Corruption Policy (PDF)

Equal Opportunity 2019-2020 Report

In accordance with the requirements of the Workplace Gender Equality Act 2012, on 30 July 2020, Mayne Pharma lodged its annual compliance report with the Workplace Gender Equality Agency.

Equal Opportunity 2019-2020 Report